Manulife (Manufacturers Life Insurance)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $98.6M | Sell |
3,512,735
-229,260
| -6% | -$6.1M | 0.08% | 222 |
|
|
2025
Q4 | $93.2M | Buy |
3,741,995
+27,047
| +0.7% | +$682K | 0.08% | 238 |
|
|
2025
Q3 | $94.7M | Buy |
3,714,948
+152,614
| +4% | +$3.77M | 0.08% | 240 |
|
|
2025
Q2 | $86.4M | Sell |
3,562,334
-17,688
| -0.5% | -$413K | 0.08% | 236 |
|
|
2025
Q1 | $90.7M | Sell |
3,580,022
-1,256,466
| -26% | -$32.9M | 0.09% | 212 |
|
|
2024
Q4 | $128M | Buy |
4,836,488
+13,681
| +0.3% | +$371K | 0.11% | 175 |
|
|
2024
Q3 | $140M | Sell |
4,822,807
-164,507
| -3% | -$4.8M | 0.12% | 179 |
|
|
2024
Q2 | $140M | Sell |
4,987,314
-243,556
| -5% | -$6.71M | 0.13% | 174 |
|
|
2024
Q1 | $145M | Sell |
5,230,870
-424,083
| -7% | -$11.8M | 0.13% | 165 |
|
|
2023
Q4 | $163M | Buy |
5,654,953
+4,568
| +0.1% | +$138K | 0.1% | 156 |
|
|
2023
Q3 | $187M | Sell |
5,650,385
-874,695
| -13% | -$30.9M | 0.11% | 134 |
|
|
2023
Q2 | $239M | Sell |
6,525,080
-264,577
| -4% | -$10.3M | 0.13% | 124 |
|
|
2023
Q1 | $277M | Sell |
6,789,657
-5,009,249
| -42% | -$216M | 0.16% | 111 |
|
|
2022
Q4 | $605M | Sell |
11,798,906
-155,458
| -1% | -$7.45M | 0.38% | 43 |
|
|
2022
Q3 | $523M | Buy |
11,954,364
+134,683
| +1% | +$6.54M | 0.36% | 51 |
|
|
2022
Q2 | $619M | Sell |
11,819,681
-4,292
| -0% | -$219K | 0.43% | 38 |
|
|
2022
Q1 | $613M | Buy |
11,823,973
+1,087,675
| +10% | +$56.4M | 0.4% | 46 |
|
|
2021
Q4 | $631K | Sell |
10,736,298
-94,155
| -0.9% | -$4.67M | 0.39% | 51 |
|
|
2021
Q3 | $466M | Buy |
10,830,453
+3,000,995
| +38% | +$133M | 0.38% | 64 |
|
|
2021
Q2 | $307M | Buy |
7,829,458
+2,313,201
| +42% | +$90M | 0.25% | 92 |
|
|
2021
Q1 | $200M | Buy |
5,516,257
+90,929
| +2% | +$3.23M | 0.17% | 138 |
|
|
2020
Q4 | $200M | Sell |
5,425,328
-560,574
| -9% | -$20.6M | 0.18% | 129 |
|
|
2020
Q3 | $208M | Buy |
5,985,902
+256,951
| +4% | +$9.01M | 0.22% | 106 |
|
|
2020
Q2 | $177M | Sell |
5,728,951
-2,435,267
| -30% | -$82.7M | 0.17% | 123 |
|
|
2020
Q1 | $253M | Buy |
8,164,218
+927,596
| +13% | +$31.6M | 0.28% | 83 |
|
|
2019
Q4 | $269M | Sell |
7,236,622
-244,455
| -3% | -$8.71M | 0.28% | 88 |
|
|
2019
Q3 | $257M | Buy |
7,481,077
+228,628
| +3% | +$8.31M | 0.29% | 88 |
|
|
2019
Q2 | $298M | Sell |
7,252,449
-402,053
| -5% | -$16M | 0.35% | 74 |
|
|
2019
Q1 | $308M | Sell |
7,654,502
-352,164
| -4% | -$14.1M | 0.33% | 74 |
|
|
2018
Q4 | $332M | Sell |
8,006,666
-1,205,452
| -13% | -$50M | 0.42% | 56 |
|
|
2018
Q3 | $385M | Sell |
9,212,118
-2,700,496
| -23% | -$104M | 0.41% | 50 |
|
|
2018
Q2 | $410M | Sell |
11,912,614
-229,033
| -2% | -$7.83M | 0.45% | 41 |
|
|
2018
Q1 | $409M | Sell |
12,141,647
-768,252
| -6% | -$26.4M | 0.45% | 44 |
|
|
2017
Q4 | $444M | Sell |
12,909,899
-1,354,365
| -9% | -$46.2M | 0.48% | 45 |
|
|
2017
Q3 | $483M | Buy |
14,264,264
+1,280,115
| +10% | +$41.1M | 0.58% | 34 |
|
|
2017
Q2 | $414M | Sell |
12,984,149
-718,974
| -5% | -$22.7M | 0.5% | 40 |
|
|
2017
Q1 | $445M | Sell |
13,703,123
-475,365
| -3% | -$15M | 0.56% | 33 |
|
|
2016
Q4 | $437M | Buy |
14,178,488
+767,531
| +6% | +$23.4M | 0.62% | 27 |
|
|
2016
Q3 | $431M | Buy |
13,410,957
+105,146
| +0.8% | +$3.52M | 0.64% | 24 |
|
|
2016
Q2 | $444M | Buy |
13,305,811
+744,381
| +6% | +$23.8M | 0.68% | 26 |
|
|
2016
Q1 | $358M | Buy |
12,561,430
+347,575
| +3% | +$9.93M | 0.31% | 57 |
|
|
2015
Q4 | $374K | Sell |
12,213,855
-1,219,996
| -9% | -$38.4M | 0.36% | 47 |
|
|
2015
Q3 | $400K | Buy |
13,433,851
+2,028,316
| +18% | +$65M | 0.42% | 43 |
|
|
2015
Q2 | $363K | Buy |
11,405,535
+835,618
| +8% | +$27.2M | 0.43% | 45 |
|
|
2015
Q1 | $349K | Buy |
10,569,917
+613,645
| +6% | +$19.5M | 0.44% | 41 |
|
|
2014
Q4 | $294K | Buy |
9,956,272
+496,131
| +5% | +$14.2M | 0.43% | 51 |
|
|
2014
Q3 | $265K | Sell |
9,460,141
-1,031,366
| -10% | -$28.9M | 0.39% | 49 |
|
|
2014
Q2 | $295M | Buy |
10,491,507
+913,184
| +10% | +$26M | 0.45% | 44 |
|
|
2014
Q1 | $292K | Buy |
9,578,323
+320,910
| +3% | +$9.57M | 0.47% | 45 |
|
|
2013
Q4 | $269K | Sell |
9,257,413
-1,103,087
| -11% | -$32.1M | 0.42% | 38 |
|
|
2013
Q3 | $282K | Sell |
10,360,500
-307,971
| -3% | -$8.38M | 0.47% | 35 |
|
|
2013
Q2 | $284M | Buy |
+10,668,471
| New | +$295M | 0.53% | 33 |
|
Other funds holding PFE
VCM
VPM
Manulife (Manufacturers Life Insurance)'s PFE Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) reduced its Pfizer (PFE) stake by 6.1% in Q1 2026, selling an estimated $6.1M and leaving 3,512,735 shares worth $98.6M. The position accounts for 0.08% of the portfolio, ranked #222.
Manulife (Manufacturers Life Insurance) first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $619M in Q2 2022. 2,940 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 3,512,735 shares of Pfizer worth $98.6M as of Q1 2026.
- Manulife (Manufacturers Life Insurance) sold 229,260 Pfizer shares in Q1 2026, an estimated $6.1M.
- Pfizer made up 0.08% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #222 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Manulife (Manufacturers Life Insurance)'s Pfizer position peaked at $619M in Q2 2022.
- 2,940 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.